{"url_path":"/fda/device/recalls/Z-2665-2026","section_key":"summary","section_title":"DEVICE Recall: Bard Access Systems, Inc. — 7617408\tGroshong NXT ClearVue Catheter 4 Fr Single-Lumen  UDI-DI Code: 00801741035258      The Groshong¿ NXT PICC provides short (less than 30 days) or long (greater than 30 days) term peripheral access to the central venous system for intravenous therapy or blood sampling.","topic":"fda","document":{"doc_type":"device-recall","doc_date":"2026-05-21","source_url":"https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2665-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Bard Access Systems, Inc."},"word_count":174,"has_tables":false,"body_markdown":"# FDA DEVICE Recall: Z-2665-2026\n\n**Recalling firm:** Bard Access Systems, Inc.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-05-21\n**Report date:** 2026-07-08\n\n## Product\n7617408\tGroshong NXT ClearVue Catheter 4 Fr Single-Lumen  UDI-DI Code: 00801741035258      The Groshong¿ NXT PICC provides short (less than 30 days) or long (greater than 30 days) term peripheral access to the central venous system for intravenous therapy or blood sampling.\n\n## Reason\nDue to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.\n\n## Affected lots\n7617408 Groshong NXT ClearVue Catheter 4 Fr Single-Lumen UDI-DI Code: 008017410352 Lot Number: REKY1686\n\n## Distribution\nWorldwide U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. The country of Belgium."}